Linking Tumor Growth Dynamics to Survival in Ipilimumab‐Treated Patients With Advanced Melanoma Using Mixture Tumor Growth Dynamic Modeling

CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1002/psp4.12454